98 related articles for article (PubMed ID: 2899182)
1. Membrane transferrin receptor (TfR) and nuclear proliferation-associated Ki-67 expression in hemopoietic malignancies.
Scott CS; Ramsden W; Limbert HJ; Master PS; Roberts BE
Leukemia; 1988 Jul; 2(7):438-42. PubMed ID: 2899182
[TBL] [Abstract][Full Text] [Related]
2. Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas.
Mitani S; Tango T; Sonobe Y; Baba N; Nagatani T; Nomoto S; Mori S
Int J Hematol; 1991 Oct; 54(5):385-93. PubMed ID: 1756249
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
[TBL] [Abstract][Full Text] [Related]
4. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between the expression of transferrin receptors (TfR) on leukemia cells and the cell proliferation and iron metabolism status in childhood acute leukemias].
Huang G; Liao Q; Luo C
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):134-6. PubMed ID: 11601239
[TBL] [Abstract][Full Text] [Related]
6. Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen.
Soyer HP; Smolle J; Smolle-Juettner FM; Kerl H
Dermatologica; 1989; 179(1):3-9. PubMed ID: 2569990
[TBL] [Abstract][Full Text] [Related]
7. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
Boldt DH; Phillips JL; Alcantara O
J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
[TBL] [Abstract][Full Text] [Related]
8. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Das Gupta A; Shah VI
Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
[TBL] [Abstract][Full Text] [Related]
9. [Expression of a proliferation associated-nuclear antigen defined by Ki-67 monoclonal antibody in childhood acute leukemia].
Ito M; Tsurusawa M; Kawai S; Fujimoto T
Rinsho Ketsueki; 1995 Aug; 36(8):713-9. PubMed ID: 7563603
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor expression of AML blasts is related to their proliferative potential.
Kozlowski R; Reilly IA; Sowter D; Robins RA; Russell NH
Br J Haematol; 1988 Jun; 69(2):275-80. PubMed ID: 3291932
[TBL] [Abstract][Full Text] [Related]
11. Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance.
Licht T; Bross KJ; Fiebig HH; Schötta K; Berger DP; Dreher C; Löhr GW; Herrmann F
J Cancer Res Clin Oncol; 1992; 118(2):116-22. PubMed ID: 1735731
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical study of transferrin receptor expression in hepatocellular carcinoma].
Lin J
Zhonghua Yi Xue Za Zhi; 1992 Feb; 72(2):86-7, 128. PubMed ID: 1327439
[TBL] [Abstract][Full Text] [Related]
13. Cell-cycle-associated expressions of proliferating cell nuclear antigen and Ki-67 reactive antigen of bone marrow blast cells in childhood acute leukemia.
Tsurusawa M; Ito M; Zha Z; Kawai S; Takasaki Y; Fujimoto T
Leukemia; 1992 Jul; 6(7):669-74. PubMed ID: 1352561
[TBL] [Abstract][Full Text] [Related]
14. [Interrelation between transferrin receptor expression and intracellular ferritin concentration in leukemia cells and normal marrow cells].
Rhyner K; Taetle R
Schweiz Med Wochenschr; 1986 Oct; 116(43):1484-7. PubMed ID: 3787230
[TBL] [Abstract][Full Text] [Related]
15. Expression of proliferation-associated nuclear antigen in human malignancies.
Pastolero GC; Mori S
Jpn J Exp Med; 1987 Jun; 57(3):193-8. PubMed ID: 2890776
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
17. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 immunoreactivity in breast carcinomas in relation to transferrin receptor expression, estrogen receptor status and morphological criteria. An immunohistochemical study.
Wrba F; Chott A; Reiner A; Reiner G; Markis-Ritzinger E; Holzner JH
Oncology; 1989; 46(4):255-9. PubMed ID: 2662089
[TBL] [Abstract][Full Text] [Related]
19. Target structure for natural killer cells: evidence against a unique role for transferrin receptor.
Dokhélar MC; Garson D; Testa U; Tursz T
Eur J Immunol; 1984 Apr; 14(4):340-4. PubMed ID: 6327320
[TBL] [Abstract][Full Text] [Related]
20. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
